Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines 73

Vaccines Compounding Pharmacies Immunization Hospitals 73

Drug Topics

JUNE 20, 2025

With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.

Vaccines 449

Vaccines Independent Pharmacies Immunization Compounding 449

Pharma Times

JULY 10, 2025

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses.

Vaccines 33

Vaccines Immunization 33

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Vaccines 52

Vaccines Communication Hospitals Packaging 52

Drug Topics

JULY 1, 2025

Reimbursements are a lot better in vaccines than it is in just filling scripts. Since you're not making money filling prescriptions until the reimbursement issue is corrected, you've got to diversify your practice and take advantage of different revenue streams with clinical services. Medication therapy management services.

Health and Personal Care Stores 544

Health and Personal Care Stores Independent Pharmacies Grocery Stores Insurance 544

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies Immunization Mayo Clinic Hospitals 65

Pharmacy Times

JULY 2, 2025

Adverse events include infusion reactions, nephrotoxicity, and ototoxicity, with pediatric patients potentially experiencing more severe reactions. The ready-to-infuse formulation simplifies administration, reducing preparation steps and enhancing treatment efficiency in healthcare settings.

FDA 73

FDA Compounding Pharmacies Compounding Hospitals 73

Pharmacy Times

JULY 14, 2025

Dave Randolph | Image courtesy of McKesson The highlight of this year’s event was the announcement of Dave’s Pharmacy in Alliance, Nebraska, as the winner of the Pharmacy of the Year Award, recognizing the pharmacy’s outstanding contributions to patient care and community health.

Independent Pharmacies 65

Independent Pharmacies Compounding Pharmacies Patient Care Hospitals 65

Drug Topics

JUNE 23, 2025

Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Health and Personal Care Stores 451

Health and Personal Care Stores CPhT Immunization Vaccines 451

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines 405

Vaccines Independent Pharmacies Immunization Compounding 405

Drug Topics

JUNE 19, 2025

The primary end point included measured GFR, and secondary outcomes included glycated hemoglobin A 1c , adverse events, diabetes ketoacidosis, hypoglycemic events, urinary and genitourinary tract infection, glycemic variability, weight, body mass index, and total daily insulin dose. Body weight also decreased by 2.8

Compounding 498

Compounding Vaccines Specialty Pharmacies Hospitals 498

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 73

Compounding Pharmacies Immunization Compounding Specialty Pharmacies 73

Drug Topics

JUNE 19, 2025

Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

CPhT 315

CPhT Independent Pharmacies Immunization Vaccines 315

Pharmacy Times

JUNE 27, 2025

Treatment-related adverse events (AEs) included nausea (77.8% vs 10.8%, respectively), and major bleeding events (2.4% 5 Primary end points included safety, with secondary end points of overall response rate (ORR), progression-free survival (PFS), and duration of response. ORRs were 94.4% in the TN cohort (95% CI, 72.7%-99.9%)

FDA 56

FDA Compounding Pharmacies Immunization Chemotherapy 56

Drug Topics

JUNE 17, 2025

Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates. J Am Pharm Assoc (2003). 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419.

Community Pharmacies 216

Community Pharmacies CPhT Immunization Vaccines 216

Drug Topics

JUNE 23, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Community Pharmacies 247

Community Pharmacies Specialty Pharmacies Compounding Independent Pharmacies 247

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 123

Compounding Pharmacies Immunization Hospitals Compounding 123

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.

Patient Care 247

Patient Care Vaccines Insurance Immunization 247

Pharmacy Times

JUNE 18, 2025

2 More recent changes in many states include the ability to prescribe oral contraceptives and plan outreach events to monitor blood pressure or cholesterol; the latter, when coupled with referral to appropriate medical services, is a valuable intervention. 2 The pharmacy profession needs to improve in 2 areas.

Immunization 65

Immunization Compounding Pharmacies Hospitals Chemotherapy 65

Pharmacy Times

JUNE 19, 2025

Nacher : I think, as I said, rusfertide being a first-in-class hepcidin mimetic is huge—especially for patients with [PV]—to hopefully reduce the phlebotomy burden and prevent some of the sequelae of the disease, including cardiovascular and thrombotic events.

Compounding Pharmacies 65

Compounding Pharmacies Immunization Hospitals Compounding 65

Pharmacy Times

JULY 12, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Independent Pharmacies 65

Independent Pharmacies Hospitals Compounding Pharmacies Immunization 65

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Immunization 50

Immunization Compounding Pharmacies Hospitals Compounding 50

Pharmacy Times

JUNE 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies FDA Immunization Mayo Clinic 65

Pharmacy Times

JUNE 23, 2025

By meticulously reviewing medication regimens, reconciling discrepancies, and providing comprehensive education to patients and caregivers, they significantly reduce the likelihood of medication errors and adverse drug events during these vulnerable periods.

Hospitals 65

Hospitals Compounding Pharmacies Vaccines Immunization 65

Pharmacy Times

JUNE 25, 2025

Ensuring patients are current on MMR vaccines is crucial due to global measles outbreaks, with specific recommendations for international travelers. SHOW MORE As summer heats up, pharmacists can provide travel vaccines and other recommendations.

Vaccines 50

Vaccines Compounding Pharmacies Immunization Compounding 50

Drug Topics

JULY 1, 2025

The primary outcomes included all-cause mortality, hospitalizations, and nonserious adverse drug events, and secondary outcomes included quality of life, emergency department visits, medical visits, injurious falls, and number of medications. medications per patient.

Long-Term Care Facilities 341

Long-Term Care Facilities Community Pharmacies Vaccines Patient Care 341

Pharmacy Times

JULY 8, 2025

The regimen maintained stem cell collection feasibility with no new safety concerns, despite some adverse events like neutropenia and infections. Five patients died during this time, with causes including disease progression (n = 1), cardiac events (n = 2), and other unrelated causes (n = 2).

Compounding Pharmacies 73

Compounding Pharmacies Immunization Compounding Specialty Pharmacies 73

Pharmacy Times

JUNE 20, 2025

Adverse events were common but comparable between dupilumab and placebo, with no deaths in the dupilumab group. 3 Overall rates of adverse events (AEs) were 96% (n = 51) in the dupilumab arm and 96% (n = 51) in the placebo.

FDA 82

FDA Compounding Pharmacies Immunization Compounding 82

Drug Topics

JUNE 23, 2025

Progress in Dermatology Paves the Way for Vaccine Development Brian Nowosielski June 20th 2025 Article Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.

Patient Care 247

Patient Care Vaccines Specialty Pharmacies Compounding 247

Drug Topics

JULY 7, 2025

link] Recent Videos Related Content Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information Ashley Gallagher ; Laura Knockel, PharmD, BCACP July 6th 2025 Article Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Mail-Order Pharmacies 281

Mail-Order Pharmacies Vaccines Specialty Pharmacies Compounding 281

PharmaVoice

JUNE 27, 2025

A long-time leader in vaccines, the U.K. Launches DSai™ — AI-Powered Digital Sign-In to Modernize HCP Event Compliance in L… From Groupize.ai Blujepa is also the first new treatment cleared for the indication in about three decades, according to GSK. Here’s how drugmakers are getting there. © 2025 TechTarget, Inc.

FDA 130

FDA Vaccines Packaging Dosage 130

Pharmacy Times

JUNE 30, 2025

REMS ensured drug safety by requiring certified hospitals to have tocilizumab for severe adverse events management. 2 Critically, a REMS designation does not automatically translate to universal mitigation of adverse events associated with a medication. Only some medications—including CAR T therapies—carry REMS designations.

FDA 100

FDA Compounding Pharmacies Immunization Hospitals 100

Pharmacy Times

JUNE 26, 2025

Participants experienced no severe hypoglycemic events, and glycated hemoglobin levels remained below 7%. Most adverse events were mild or moderate, with no serious events linked to zimislecel. Serious adverse events occurred in 6 individuals, leading to extended hospitalization. 1,2 REFERENCES 1.

Compounding Pharmacies 92

Compounding Pharmacies Hospitals Vaccines Immunization 92

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What role do you see pharmacists playing in the discussions and advancements presented at the event? There are going to be a lot of key takeaways that will be important for the pharmacist to know. Isaacs: It's great if pharmacists can be there, but even if not, there's a virtual option as well.

Compounding Pharmacies 81

Compounding Pharmacies Immunization FDA Hospitals 81

Pharmacy Times

JUNE 17, 2025

Among the 37 practices that reported waste, 768 events were reported, leading to a total drug waste of $11,275,642.16. These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. compared with $546,082.45 for the external mail-order pharmacies. Of that, $8,935,612.15

Mail-Order Pharmacies 73

Mail-Order Pharmacies Compounding Pharmacies Medical Records Dosage 73

Pharmacy Times

JULY 2, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65